The study was designed to evaluate the effectiveness of Potassium glycyrrhizinate as hepatoprotective and hepatocurative agent. For this purpose, eight groups of healthy albino rabbits were selected, each comprising 5 rabbits with average weight of 1.36 kg. Group A & Group B animals served as control and placebo respectively while rest of six groups i.e. D,E,F,G and H were administered different doses of paracetamol suspension with a range from 800-3000 mg/kg in order to raise transaminase enzymes (SGOT, SGPT) in experimental animals. The blood samples (34ml) were collected at time 0 hr (before drugs administration), 6, 24 and 48 hrs after drugs administration and serum levels (U/L) of SGOT & SGPT were measured spectrophotometerically. After 48hrs of paracetamol dosing, Potassium glycyrrhizinate (15mg/kg/day) was administered to Groups D & E (now Treated groups 1 & 2) and 30mg/kg/day of the same drug to Groups F & G (now Treated Groups 3 & 4) for 7 days. Blood samples were collected on day 0 ( before drug administration) 2nd, 6th and 9th days of treatment, the serum levels of SGOT & SGPT were measured.The data were analyzed to calculate mean & standard error by SPSS version 1.0. The study concludes that Potassium glycyrrhizinate reduces SCOT and SGPT levels, revealing hepatoprotective and hepatocurative activity.